Rather than making medical claims, the beverage is structured as a lifestyle addition designed to complement broader wellness habits
Lixisenatide is an exendin-derived GLP-1RA for which PPG lowering is brought about mostly through delayed gastric emptying and reduced glucagon release
December 4th, 2025: New Study Links GLP-1 Drugs to Increased Incidence of Chronic Cough A peer-reviewed study published on November 26 in JAMA Otolaryngology Head & Neck Surgery reports that GLP-1 medications such as Ozempic and Mounjaro are associated with higher rates of chronic cough compared to several other second-line diabetes treatments
The peptide is used in conjunction with a PDE-5 inhibitor
Thought Leadership in Action: What This Means for Suppliers For peptide API manufacturers, the message is clear: Now is the time to scale peptide production capabilities Regulatory readiness (DMFs, COAs, Zone IVB stability) is non-negotiable Strategic partnerships with R&D buyers, CDMOs, and local market leaders will unlock early market access and competitive advantage At Global Pharma Tek, we dont just follow trendswe help shape them
Companies including Aspen Pharmacare, Vimy Pharma, and others have indicated summer 2026 launch targets for their generic versions
